The Gross Margin of Lionco Pharmaceutical Group Co Ltd (603669.SS) is 44.50%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 44.50% |
| 2022-12-31 | 67.47% |
| 2021-12-31 | 79.16% |
| 2020-12-31 | 84.37% |
| 2019-12-31 | 86.28% |
| 2018-12-31 | 87.85% |
| 2017-12-31 | 80.00% |
| 2016-12-31 | 57.54% |
| 2015-12-31 | 60.01% |
| 2014-12-31 | 60.81% |